Recent Finacing
Recent Raise
Praxis Precision Medicines is a clinical-stage biopharmaceutical company in Cambridge developing genetically informed, mechanism-targeted therapies for CNS disorders, with clinical programs PRAX-114, PRAX-944 and PRAX-562.
